People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hycor Holdings Inc. | — | Biotechnology | Series C | $109.6M | $210.8M | 2017 |
Fei Li at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fei Li on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yan Zhang | 1 | 4 |
| Hui Liu | 1 | 2 |
| Weixi GAO | 1 | 1 |
| Xuetao Jiang | 1 | 1 |
| Zirun ZHU | 1 | 1 |
| Hui Zhou | 1 | 1 |
| Miao Shuke | 1 | 1 |
| Xiao Huang | 1 | 1 |
| Yuntao Zhong | 1 | 1 |
| Chen LIU | 1 | 1 |
| Zhu Zirun | 1 | 1 |
| Zhang Yan | 1 | 1 |
| Xiaoyan Lu | 1 | 1 |
| Richard Aderman | 1 | 1 |
| Xiaoqin Ji | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.